National and Kapodistrian University of Athens
Η ανοσοτροποποιητική δράση της θαλιδομίδης στη θεραπευτική αντιμετώπιση της πειραματικής σήψης από πολυανθεκτική Pseudomonas aeruginosa
Abstract
dc:descriptionBackground: To evaluate whether thalidomide which is an inhibitor of tumor necrosis factor-alpha (TNF-a) might behave as an effective immunomodulator in experimental sepsis by multidrug-resistant Pseudomonas aeruginosa. Methods: Sepsis was induced by the intraperitoneal injection of 1x10⁸ cfu/kg inoculums of the test isolate in a total of 109 wistar rats divided in three groups as follows. Group A: controls, group B: administered 50mg/kg of thalidomide diluted in seed oil 30 minutes before bacterial challenge. Blood was sampled for estimation of endotoxins (LPS), TNF-a, IFNγ, NO and MPA. LPS was measured by the QCL-1000 LAL assay, TNF-a and IFNγ by ELISA, ΝΟ by a colorimetric assay and MDA by the thiobarbiturate assay. Results: Mean (ISE) survival of groups A, B and C were 18.60 ± 1.84, 12.60 ± 0.60 and 30.50 ± 6.62 hours (p of comparisons A to C equal to 0.043 and B to C equal to 0.002). Decreased TNF-a and NO levels were found in sera of animals of group C compared to group A. Plasma levels of LPS, MDA and IFNγ did not differ between groups. Conclusions: Intake of thalidomide considerably prolonged survival in experimental sepsis by MDP P. Aeruginosa on effect probably attributed to decrease of serum TNF-a.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bolanos, Nikolaos
- Μπολάνος, Νικόλαος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27154